Loading
Latest filing published 21 May 2026 for Pharmala Biotech Holdings Inc..
No signal scores available.
Lennie Ryer discloses dealings in Pharmala Biotech Holdings Inc. to SEDI. Between 9 February 2026 and 8 May 2026, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 1 purchase worth €3,369, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 21 May 2026, the filings show a transaction in Pharmala Biotech Holdings Inc. The last insider purchase was made public on 21 May 2026, 156 days ago. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations